Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index

International Journal of Clinical Oncology

Volumn 20, Issue 2, 2015, Pages 317-323

  Santa Maria, Cesar Augusto ^a   Yan, Jingsheng ^b   Xie, Xian Jin ^b   Euhus, David Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aggressive phenotype; Breast cancer; Histologic grade; Ki67; Obesity

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; BODY MASS; BREAST NEOPLASMS; CANCER GRADING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMISTRY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERLIPIDEMIAS; HYPERTENSION; MIDDLE AGED; OBESITY; PATHOLOGY; PREMENOPAUSE; PREVALENCE; TUMOR INVASION; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; OBESITY; PREMENOPAUSE; PREVALENCE; RECEPTORS, ESTROGEN;

EID: 84939883187     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0712-4     Document Type: Article

References (32)

1. Food, nutrition, physical activity and the prevention of cancer: a global perspective (2007). World Cancer Research Fund/American Institute for Cancer Research, Washington, DC
2. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627–635
3. Ryu SYKC, Nam CM, Park JK et al (2001) Is body mass index the prognostic factor in breast cancer?: a meta-analysis. J Korean Med Sci 16(5):610–614
4. Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118(23):5937–5946
5. Griggs JJ, Sorbero ME, Lyman GH (2005) Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165(11):1267–1273. doi:10.1001/archinte.165.11.1267
6. Carroll J, Protani M, Walpole E et al (2012) Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat 136(2):323–330. doi:10.1007/s10549-012-2213-3
7. Griggs JJ, Mangu PB, Anderson H et al (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30(13):1553–1561. doi:10.1200/JCO.2011.39.9436
8. Folkerd EJ, Dixon JM, Renshaw L et al (2012) Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer. J Clin Oncol 30(24):2977–2980. doi:10.1200/JCO.2012.42.0273JCO.2012.42.0273
9. Chlebowski R, McTiernan A, Wactawski-Wende J et al (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 30(23):2844–2852
10. Khan S, Shukla S, Sinha S et al (2013) Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev 24(6):503–513
11. Yanai A, Miyagawa Y, Murase K et al (2013) Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers. Int J Clin Oncol [Epub ahead of print]
12. Obesity: preventing and managing the global epidemic. Report of a WHO consultation (2000) vol 894
13. IOM (Institute of Medicine): the role of obesity in cancer survival and recurrence: workshop summary. (2012) Washington, DC
14. Flegal KM, Carroll MD, Kit BK et al (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307(5):491–497
15. Wing RR, Matthews KA, Kuller LH et al (1991) Weight gain at the time of menopause. Arch Intern Med 151(1):97–102
16. Dawood S, Lei X, Litton JK et al (2012) Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 12(5):364–372
17. Ries LAG, Eisner MP, Kosary CL (2001) SEER cancer statistics review, 1973–1998, National Cancer Institute
18. CDC (2011) Vital signs: prevalence, treatment, and control of hypertension—United States, 1999–2002 and 2005–2008. MMWR 60(4):103–108
19. Kuklina EV, Shaw KM, Hong Y (2011) Vital Signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol—United States, 1999–2002 and 2005–2008. MMWR 60(04):109–114
20. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States (2011) U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
21. Christiansen N, Chen L, Gilmore J et al (2012) Association between African American race and outcomes in patients with nonmetastatic triple-negative breast cancer: a retrospective analysis by using results from the Georgia Cancer Specialist Database. Clin Breast Cancer 12(4):270–275
22. Sparano JA, Wang M, Zhao F et al (2012) Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst 104(5):406–414
23. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–410
24. Deurenberg P, Yap M, van Staveren WA (1998) Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22(12):1164–1171
25. Abbasi F, Blasey C, Reaven GM (2013) Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr 98(3):637–640
26. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf. Accessed 20 Jan 2014
27. Polley MY, Leung SC, McShane LM et al (2013) An international Ki67 reproducibility study. J Natl Cancer Inst 105(24):1897–1906
28. Meyer JS, Alvarez C, Milikowski C et al (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 18(8):1067–1078
29. Moller DE, Flier JS (1991) Insulin resistance—mechanisms, syndromes, and implications. N Engl J Med 325(13):938–948
30. Cleary MP, Grossmann ME (2009) Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 150(6):2537–2542. doi:10.1210/en.2009-0070
31. Simpson E, Brown KA (2013) Obesity and breast cancer: role of inflammation and aromatase. J Mol Endocrinol 51(3):T51–T59. doi:10.1530/JME-13-0217
32. Cho Y, Sung M, Yeon J et al (2013) Prognostic role of interleukin-6, interleukin-8, and leptin levels according to breast cancer subtype. Cancer Res Treat 45(3):210–219